Insights on caregiving, product updates, latest research update and how Dez works for families and healthcare providers.
More than 55 million people live with dementia. A clinical and economic analysis for health systems and insurers: 3.5-year diagnostic delay, $781B US cost, blood-based biomarkers, lecanemab and donanemab, unpaid caregiver burden, and up to 45–49% potentially preventable cases.
Read more →
ALS care is built around clinic visits every few months, yet the disease progresses every day at home. This piece looks at who bears that gap, what changes between visits, and why continuity drives outcomes in practice, not a better snapshot on its own.
Read more →
Big tech is sprinting to own Health OS. For 1.8 billion wearable users that matters. But 43 million people died from non-communicable diseases in 2021, and the device-to-consumer stack was never built for them.
Read more →
For millions of families, care is not occasional. It is managed every day. Spinal muscular atrophy (SMA) shows why home-based signals, timing, and access matter as much as clinical visits.
Read more →
Healthcare is supposed to be evidence-based, yet the majority of real-world health evidence is never captured. Most care happens at home.
Read more →
Care gets more complex outside of the hospital environment
Read more →Be among the first to use Dez in your family.
Explore the Dez app